Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Testing effectiveness (Phase 2)UnknownNCT03510416
What this trial is testing

Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization
Shanghai Zhongshan Hospital 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07350070
What this trial is testing

TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension

Who this might be right for
HCCLiver CirrhosisPortal Hypertension
Tongji Hospital 78
Not applicableLooking for participantsNCT04115254
What this trial is testing

Stereotactic Magnetic Resonance Guided Radiation Therapy

Who this might be right for
Pancreas CancerLung CancerRenal Cancer+10 more
Dana-Farber Cancer Institute 397
Not applicableStudy completedNCT04172194
What this trial is testing

Endoarterial Treatment in Combination With Percutaneous Thermoablation for Medium-sized and Oligonodular Hepatocellular Carcinomas

Who this might be right for
Carcinoma, Hepatocellular
Centre Hospitalier Universitaire de Nice 64
Not applicableUnknownNCT01930383
What this trial is testing

Circulating Tumor Cells for Hepatocellular Carcinoma

Who this might be right for
Carcinoma, HepatocellularNeoplasm Circulating Cells
National Taiwan University Hospital 150
Early research (Phase 1)Study completedNCT02960594
What this trial is testing

HTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

Who this might be right for
Breast CancerLung CancerPancreatic Cancer+6 more
Inovio Pharmaceuticals 93
Post-approval studies (Phase 4)UnknownNCT05416073
What this trial is testing

Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTransarterial ChemoembolizationHepatic Arterial Infusion Chemotherapy+1 more
The Second Affiliated Hospital of Chongqing Medical University 70
Not applicableUnknownNCT05575622
What this trial is testing

Clinical Study for Combined Analysis of CTC and Exosomes on Predicting the Efficacy of Immunotherapy in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhongnan Hospital 200
Not applicableStudy completedNCT02366286
What this trial is testing

Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants

Who this might be right for
Hepatitis BHepatitis CCarcinoma, Hepatocellular
Mayo Clinic 892
Not applicableEnrolling By InvitationNCT04195503
What this trial is testing

Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
University Health Network, Toronto 10
Not applicableNot Yet RecruitingNCT07618546
What this trial is testing

A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors

Who this might be right for
HCC - Hepatocellular Carcinoma
Henan Cancer Hospital 208
Testing effectiveness (Phase 2)Study completedNCT01357486
What this trial is testing

Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCHILD B
University Hospital, Bordeaux 160
Large-scale testing (Phase 3)Looking for participantsNCT04803994
What this trial is testing

The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 434
Not applicableStudy completedNCT04920019
What this trial is testing

Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery

Who this might be right for
HepatomaPancreas Cancer
Mahidol University 140
Not applicableStudy completedNCT07272265
What this trial is testing

The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 300
Not applicableLooking for participantsNCT06746701
What this trial is testing

Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.

Who this might be right for
HBV
Xiangya Hospital of Central South University 400
Testing effectiveness (Phase 2)Study completedNCT02089919
What this trial is testing

Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients

Who this might be right for
Neoplasms, Liver
Fuda Cancer Hospital, Guangzhou 40
Not applicableStudy completedNCT07193316
What this trial is testing

Safety and Efficacy of Atezolizumab-Bevacizumab Versus Tyrosin Kinase Inhibitors in Patients With Liver Cirrhosis

Who this might be right for
Hepatocellular CarcinomaLiver Cirrhosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 38
Testing effectiveness (Phase 2)UnknownNCT05214339
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET)

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma by BCLC Stage
Sun Yat-sen University 30
Next Page